title: Facing the dawn of immunotherapy for hepatocellular carcinoma.
authors.forename: Martin F
authors.initials: MF
authors.lastname: Sprinzl
authors.forename: Peter R
authors.initials: PR
authors.lastname: Galle
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D060908:CTLA-4 Antigen / Q000037:antagonists & inhibitors*; D006528:Carcinoma, Hepatocellular / Q000150:complications* / Q000628:therapy*; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000628:therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications* / Q000628:therapy*; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D060908:CTLA-4 Antigen; C520704:tremelimumab